For the first time in 20 years, the FDA has released draft guidance on how pharmaceutical companies can communicate healthcare economic information (HCEI) with payers. Although there is no change in the types of information that can be shared, the guidance will likely clarify how that information can be shared.

“This can be a net positive for industry if they embrace it and update their ways of working,” says Intouch’s group director of market access, Peter Weissberg, in a January 24, 2017, MM&M article on the topic.

Read the entire article, and more of Peter’s thoughts on the subject, here.